Schumer moves forward on Medicare drug price negotiations with Manchin's support — reports

Paul Schloesser

Associate Editor

Nicole DeFeudis

Editor

Months after Sen. Joe Manchin (D-WV) essentially squashed Democrats’ hopes of passing the Build Back Better Act, which included proposals to lower drug prices, a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Schumer moves forward on Medicare drug price negotiations with Manchin's support — reports

Paul Schloesser

Associate Editor

Nicole DeFeudis

Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

Are programs with compounded GLP-1s safe for your population?

Schumer moves for­ward on Medicare drug price ne­go­ti­a­tions with Manch­in's sup­port — re­ports

Associate Editor

Editor

Sign up to read this article for free.

Schumer moves forward on Medicare drug price negotiations with Manchin's support — reports